EMA And FDA Compared – The Case Of Minoryx’s Leriglitazone

 
• By Francesca Bruce
  
Pathway
EU and US regulators take a different approach to Minoryx's orphan drug leriglitazone • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography